Staying Real in Israel
Home of
"The Marty Roberts Show"

Lot’s of people do not avail themselves of the most effective exam for preventing colon cancer…colonoscopy…

Granted, the preparation for the test is a bit unpleasant, although the test itself is a big nothing, many avoid the potentially life-saving procedure (it probably saved MY life 6 years ago, but that’s another story…)
Well, thanks to Israeli innovation, here’s an alternative that’s just too good to refuse…

Given Imaging launches trial for colonoscopy alternative

The PillCam Colon trial will encompass 800 patients who are at average risk for colonic polyps.

Reprinted from Globes.co.il

Capsule endoscopy company Given Imaging Ltd. (Nasdaq: GIVN; TASE:GIVN) reported today that it has initiated its first trial of PillCam Colon 2. The capsule will be tested in a large, multi-center pivotal study, ahead of an application to the US Food and Drug Administration (FDA).

800 patients, aged 50-75 years, who are at average risk for colonic polyps and comprise the normal screening population will be recruited by Given Imaging at 17 locations.

Prof. Douglas Rex of Indiana University School of Medicine, and Director of Endoscopy, Indiana University Hospital said, “While colonoscopy remains the most effective test for colorectal cancer screening, not everyone is willing to undergo colonoscopy. Only half of eligible Americans have had a screening test, so we welcome additional tools that can help us increase compliance and lower the incidence of colorectal cancer.”

He added, “We recently completed a survey demonstrating that patients who are noncompliant with their physician’s recommendation for a colonoscopy for colorectal cancer screening would prefer PillCam COLON capsule endoscopy over other screening modalities. Aspects of PillCam that are attractive include that it’s less invasive, detects polyps better than some of the alternative tests and does not require either sedation or a driver to accompany the patient.”

Given Image’s share was down 1.11% on Nasdaq in afternoon trading today to $21.30, giving a market cap of $639.58 million.